The Forefront of Innovation

About Us

Scientist is on a mission to empower and connect researchers worldwide. By enabling scientists to easily Outsource Everything But the GeniusTM, we are pioneering a faster, leaner and more innovation-centric approach to research. Our vision is to create a world in which scientists are limited only by their imagination.

Our partners include large and small pharmaceutical and biotechnology companies, crop science companies, cosmetic companies, Contract Research Organizations (CROs), government research institutes, university core facilities, academic researchers and citizen scientists.

Management

Kevin Lustig, PhD
CEO & President

Kevin is a scientist-entrepreneur with 30 years of research experience in academia and pharma. He co-founded Scientist.com in 2007. In 2001, he co-founded Kalypsys, a small pharmaceutical company. He was Director of Lead Discovery at Tularik from 1997-2001. He carried out postdoctoral work at Harvard Medical School after receiving a PhD degree from Marc Kirschner’s laboratory at UC-San Francisco and an A.B. degree, magna cum laude, from Cornell University.

Chris is a software engineer who has worked extensively with drug researchers to develop online solutions to complex scientific processes. He co-founded Scientist.com in 2007. From 2002-2006 he was Director of Software Development at Kalypsys, a small pharmaceutical company. He was Director of Engineering at Learning Framework from 1999-2001. Chris received a B.S. degree in Computer Science from Worcester Polytechnic Institute, where he received the Provost’s award.

Dan is a bioengineer who has worked extensively with life science start-up companies. Prior to joining Scientist.com, he advised startups at eBoost Consulting, started a company called ChemoTactics and was the CTO of the UC-San Diego 100K Entrepreneur Challenge. In 2012, Dan was selected as a Siebel Scholar. Dan received an M.S. and Ph.D in Bioengineering from Joseph Wang’s lab at UCSD, where he was a Gordon Scholar. He received a B.S. degree, summa cum laude, from Rutgers in 2006.

Board Of Directors

SCI-PHinshaw

Parker Hinshaw

Bootstrap Ventures


Parker Hinshaw was previously the CEO/founder of maxIT Healthcare, a consulting services company that was sold in 2015 for $500M+. He is now senior vice president of business development for MD Revolution. A successful leader over his 35-year career, Parker now sits on the boards and advises multiple innovative organizations and start-ups. Parker received a Bachelor of Business Administration (BBA) from Indiana University.

SCI-BMunos

Bernard Munos, PhD

Founder, InnoThink Center for Research in Biomedical Innovation


Bernard is the founder of InnoThink. In 2014, the popular industry publication FiercePharma named him one of the 25 most influential people in biopharmaceuticals today. Bernard received an MBA from Stanford University and he holds graduate degrees from the UC-Davis and the Paris Institute of Technology for Life, Food and Environmental Sciences. He serves on the Advisory Council and the Cures Acceleration Network Review Board of NIH’s NCATS.

SCI-AMartin

Andrew B. Martin, PhD

Informatics Specialist, Stanford University School of Medicine


Andy is an informatics expert specializing in the organization, analysis and visualization of big data. He co-founded Scientist.com in 2007. Currently, he builds tools to securely store clinical patient data at Stanford University. From 1999-2006, he was head of informatics at Kalypsys, a small pharmaceutical company. He received a PhD degree in Chemistry from Peter Schultz’s laboratory at the UC-Berkeley and a B.A. degree magna cum laude from Carleton College.

Kevin

Kevin Lustig, PhD

CEO and President, Scientist


Kevin is a scientist-entrepreneur with 30 years of research experience in academia and pharma. He co-founded Scientist.com in 2007. In 2001, he co-founded Kalypsys, a small pharmaceutical company. He was Director of Lead Discovery at Tularik from 1997-2001. He carried out postdoctoral work at Harvard Medical School after receiving a PhD degree from Marc Kirschner’s laboratory at UC-San Francisco and an A.B. degree, magna cum laude, from Cornell University.

Scientific Advisory Board

SCI-T-Torphy

Ted J. Torphy, PhD

Chief Science Officer, BioMotiv


With more than 30 years of experience in pharmaceutical R&D, Ted has been instrumental in the discovery and development of multiple marketed products. Since 2004 he has chaired the board of The Cystic Fibrosis Foundation Therapeutics, Inc. Ted currently serves as CSO of BioMotiv. Prior to that, Ted spent 12 years with Johnson & Johnson in high ranking managerial positions. Before Johnson & Johnson, Ted spent 17 years with SmithKline Beecham in various VP tier roles. He holds a B.S. degree in Pharmacy from the University of Wisconsin and a Ph.D. in Pharmacology and Toxicology from West Virginia University.

SCI-RDeshais

Ray Deshais, PhD

Professor & Executive Officer of Biology Caltech


Deshaies received his BS in biochemistry from Cornell University and his PhD in biochemistry from the University of California, Berkeley. He was a Lucille P. Markey Charitable Trust Postdoctoral Scholar at UCSF. His honors include a Searle Scholar Award, a Beckman Young Investigator Award, a Burroughs Wellcome Fund New Investigator Award in the basic pharmacological sciences, and appointment as a Fellow of the American Association for the Advancement of Science. In 2011, Ray was elected to the AAAS. In addition to his academic work, Dr. Deshaies co-founded Proteolix in 2003. In 2011, Dr. Deshaies co-founded Cleave Biosciences.

SCI-RKing

Randall W. King, MD PhD

Professor, Harvard Medical School


Randall is a Professor in the Department of Cell Biology at Harvard Medical School. Prior to joining the faculty at Harvard Medical School, Dr. King was a fellow at the Institute of Chemistry and Cell Biology at Harvard, where he developed new approaches in chemical genetics. Dr.King co-founded the drug discovery company Kalypsys in 2001, and served on its science advisory board for four years. He received an MD from Harvard Medical School after receiving a PhD from Mark Kirschner’s laboratory at the University of California, San Francisco. He received a B.A. degree in chemistry from Carleton College.

SCI-AButte

Atul Butte, MD PhD

Director of the Institute for Computational Health Sciences; Executive Director of Clinical Informatics for UC Health Sciences and Services and Professor of Pediatrics at UCSF


Atul is Director of the Institute for Computational Health Sciences and Professor of Pediatrics at UCSF. Atul studied Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, then received his PhD in Health Sciences and Technology from Harvard Medical School and MIT. He is also a founder of Personalis and NuMedii. Atul authored more than 120 publications and delivered more than 140 presentations. His recent awards include the 2011 National Human Genome Research Institute Genomic Advance of the Month and the 2010 Society for Pediatric Research Young Investigator Award.

SCI-Jtheriot

Julie A. Theriot, PhD

Professor, Stanford University


Julie is a Professor at the Stanford University School of Medicine, with appointments in the Department of Biochemistry and the Department of Microbiology & Immunology. Her group has developed computational, analytical and statistical methods for large-scale quantitative image and motion analysis. She has numerous awards for both research and teaching, including a MacArthur Foundation fellowship in 2004. Prior to 1997, Dr. Theriot was a Whitehead Fellow at the Whitehead Institute for Biomedical Research. She received a PhD in Cell Biology from the University of California at San Francisco in 1993, and BS degrees in Biology and Physics from MIT in 1988.

SCI-BConklin

Bruce Conlin, MD

Sr Investigator Gladstone Inst. and Professor UCSF


Bruce is a Senior Investigator at the Gladstone Institute and a Professor at the University of California, San Francisco. Dr. Conklin received an A.B. degree in public health from UC Berkeley in 1982. He completed an MD degree at Case Western Reserve University in Cleveland in 1988. From 1995 to 2001, Dr. Conklin was the Associate Director of the General Clinical Research Center at San Francisco General Hospital. Dr. Conklin was the co-chair of the UCSF public science project in 1994, and is co-chair of the UCSF-California Academy of Sciences Affiliation Task Force.